Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Industrivärden is a Swedish listed investment and holding company focused on long-term active ownership in a concentrated portfolio of large Nordic public companies. Rather than operating as a biotech, pharma, or healthcare developer, it creates value through governance, capital allocation, and strategic involvement in its holdings. Its portfolio has included major industrial, engineering, banking, forest products, telecom, and construction companies such as Volvo, Sandvik, Handelsbanken, Essity, SCA, Skanska, Ericsson, and Alleima. For a biotech analyst, the key point is that Industrivärden is not a life sciences operating company and does not maintain a therapeutic R&D pipeline; it is a financial owner and public-market investment vehicle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Industrivärden.